English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24216476      Online Users : 48
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34395

    標題: Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
    作者: Chen, Bao-Yu
    Lin, Jin-Jia
    Lu, Ming-Kun
    Tan, Hung-Pin
    Jang, Fong-Lin
    Lin, Sheng-Hsiang
    貢獻者: Natl Cheng Kung Univ, Coll Med, Inst Clin Med
    Chi Mei Med Ctr, Dept Psychiat
    Jianan Mental Hosp, Dept Hlth
    Chia Nan Univ Pharm & Sci, Dept Appl Life Sci & Hlth
    Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth
    Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth
    Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med
    日期: 2021
    上傳時間: 2023-11-11 11:49:29 (UTC+8)
    摘要: Early-onset schizophrenia (EOS) may have stronger familial aggregation and a more severe outcome than adult-onset schizophrenia (AOS). MicroRNA (miRNA) takes on dual roles as a genetic and epigenetic modulator, which may mediate the influence of genetic risk. Neurological soft signs (NSS) are neurological abnormalities that may be intermediate phenotypes or endophenotypes for schizophrenia. Our previous study found poorer performance on NSS tests from patients with EOS and their unaffected first-degree relatives. Thus, we aimed to identify a set of aberrant neurodevelopmental-related miRNAs that could serve as potential biomarkers for EOS or schizophrenia with NSS. This study included 215 schizophrenia patients (104 EOS and 111 AOS), 72 unaffected first-degree relatives, 31 patients with bipolar disorder, and 100 healthy controls. Differential expression analysis revealed that miR-137, miR-34b, and miR-34c were significantly up-regulated in patients with schizophrenia and their unaffected first-degree relatives compared to healthy controls. Receiver operating characteristic (ROC) analysis showed that the miR-137 expression signature could be used to discriminate between patients with EOS and healthy controls (AUC = 0.911). Additionally, miR-34b had the highest ability to discriminate between EOS and AOS (AUC = 0.810), which may indicate different aetiological pathways to disease onset. Moreover, miR-137 dysregulation was correlated with almost all NSS subscales (i.e., sensory integration, motor sequencing, etc.) and, when EOS patients with NSS, miR-137 expression discriminated these patients from healthy controls to a greater extent (AUC = 0.957). These findings support the potential for neurodevelopmental-related miRNAs to be used as indicators of vulnerability to EOS.
    關聯: NPJ SCHIZOPHR, v.7, n.1
    Appears in Collections:[生活保健科技系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    s41537-021-00164-1.pdf1498KbAdobe PDF34View/Open

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback